Vol 75, No 3 | The Journal of Clinical Psychiatry

Review Article

Review of Maintenance Trials for Major Depressive Disorder: A 25-Year Perspective From the US Food and Drug Administration

J Clin Psychiatry 2014;75(3):205-214

Silvana Borges, MD ; Yeh-Fong Chen, PhD ; Thomas P. Laughren, MD ; Robert Temple, MD ; Hiren D. Patel, PharmD ; Paul A. David, RPh ; Mitchell Mathis, MD ; Ellis Unger, MD ; Peiling Yang, PhD ; Ni A. Khin, MD

Original Research

Completed and Attempted Suicides Among 18,154 Subjects With Schizophrenia Included in a Large Simple Trial

J Clin Psychiatry 2014;75(3):e184-e190

W. Wolfgang Fleischhacker, MD ; John M. Kane, MD ; Jamie Geier, PhD ; Onur Karayal, MD, MPH ; Sheela Kolluri, PhD ; Sybil M. Eng, PhD ; Robert F. Reynolds, ScD ; Brian L. Strom, MD, MPH

Original Research

Violent and Serious Suicide Attempters: One Step Closer to Suicide?

J Clin Psychiatry 2014;75(3):e191-e197

Lucas Giner, MD, PhD ; Isabelle Jaussent, PhD ; Emilie Olié, MD ; Séverine Béziat, MSc ; Sebastien Guillaume, MD, PhD ; Enrique Baca-García, MD, PhD ; Jorge Lopez-Castroman, MD, PhD ; Philippe Courtet, MD, PhD

Original Research

Cost-Effectiveness of Prolonged Exposure Therapy Versus Pharmacotherapy and Treatment Choice in Posttraumatic Stress Disorder (the Optimizing PTSD Treatment Trial): A Doubly Randomized Preference Trial

J Clin Psychiatry 2014;75(3):222-230

Quang A. Le, PharmD, PhD ; Jason N. Doctor, PhD ; Lori A. Zoellner, PhD ; Norah C. Feeny, PhD

Original Research

Do Clinical Trials of Treatment of Alcohol Dependence Adequately Enroll Participants With Co-Occurring Independent Mood and Anxiety Disorders? An Analysis of Data From the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC)

J Clin Psychiatry 2014;75(3):231-237

Nicolas Hoertel, MD ; Bruno Falissard, MD, PhD ; Keith Humphreys, PhD ; Philip Gorwood, MD, PhD ; Anne-Sophie Seigneurie, MD ; Frédéric Limosin, MD, PhD

Original Research

Trends in Office-Based Mental Health Care Provided by Psychiatrists and Primary Care Physicians

J Clin Psychiatry 2014;75(3):247-253

Mark Olfson, MD, MPH ; Kurt Kroenke, MD ; Shuai Wang, PhD ; Carlos Blanco, MD, PhD

Article

A Prospective 4-Year Naturalistic Follow-Up of Treatment and Outcome of 300 Bipolar I and II Patients

J Clin Psychiatry 2014;75(3):254-263

Christian Simhandl, MD, PhD ; Barbara König, PhD ; Benedikt L. Amann, MD, PhD

Commentary

Schizophrenia: The Role of Dopamine and Glutamate

J Clin Psychiatry 2014;75(3):274-275

Anissa Abi-Dargham, MD ; Jonathan M. Meyer, MD

Clinical and Practical Psychopharmacology

Antidepressants and Testicular Cancer: Cause Versus Association

J Clin Psychiatry 2014;75(3):e198-e200

Chittaranjan Andrade, MD

ASCP Corner

The Endocannabinoid System and Schizophrenia: Links to the Underlying Pathophysiology and to Novel Treatment Approaches

J Clin Psychiatry 2014;75(3):285-287

Swapnil Gupta, MBBS, MD ; John D. Cahill, MBBS ; Mohini Ranganathan, MD ; Christoph U. Correll, MD

Letter to the Editor

High-Dose Cholinergic Therapy With Rivastigmine Patch Does Not Prolong QTc Time in Patients With Alzheimer's Disease

J Clin Psychiatry 2014;75(3):288

Matthias W. Riepe, MD, Dipl-Phys

Letter to the Editor

The Problem of Patient Heterogeneity and Lack of Proper Training in a Study of EEG Neurofeedback in Children

J Clin Psychiatry 2014;75(3):289-290

Rex L. Cannon, PhD ; H. E. Pigott, PhD ; Tanju Surmeli, MD ; Deborah R. Simkin, MD ; Robert W. Thatcher, PhD ; Werner Van den Bergh, MD ; Gerald Gluck, PhD ; Joel F. Lubar, PhD ; Richard Davis, MS ; Dale S. Foster, PhD ; Jonathan Douglas, PhD ; Atholl T. Malcolm, PhD ; Donald Bars, PhD ; Kirk Little, PsyD ; Wes Center, PhD ; Marvin Berman, PhD ; Harold Russell, PhD ; Barbara Hammer, PhD ; J. Lucas Koberda, MD, PhD

Letter to the Editor

Dr van Dongen-Boomsma and Colleagues Reply

J Clin Psychiatry 2014;75(3):290

Martine van Dongen-Boomsma, MD ; Madelon A. Vollebregt, MSc ; Dorine Slaats-Willemse, PhD ; Jan K. Buitelaar, MD, PhD

Letter to the Editor

Correction: Continuation of Quetiapine Versus Switching to Placebo or Lithium for Maintenance Treatment of Bipolar I Disorder (Trial 144: A Randomized Controlled Study)

J Clin Psychiatry 2014;75(3):290

Educational Activity

Misdiagnosis of Bipolar Depression in Primary Care Practices

J Clin Psychiatry 2014;75(3):e05

Larry Culpepper, MD, MPH

Educational Activity

Common Comorbidities and Differential Diagnosis of Restless Legs Syndrome

J Clin Psychiatry 2014;75(3):e06

William G. Ondo, MD

Educational Activity

Presentation and Treatment of Complicated Obsessive-Compulsive Disorder

J Clin Psychiatry 2014;75(3):e07

Charles F. Brady, PhD, ABPP

Book Review

Cognitive-Behavior Therapy for Children and Adolescents

J Clin Psychiatry 2014;75(3):e201

Scott Temple, PhD

Volume 75 • 2014 • 3

Review Article

Review of Maintenance Trials for Major Depressive Disorder: A 25-Year Perspective From the US Food and Drug Administration

Original Research

Completed and Attempted Suicides Among 18,154 Subjects With Schizophrenia Included in a Large Simple Trial

Violent and Serious Suicide Attempters: One Step Closer to Suicide?

Cost-Effectiveness of Prolonged Exposure Therapy Versus Pharmacotherapy and Treatment Choice in Posttraumatic Stress Disorder (the Optimizing PTSD Treatment Trial): A Doubly Randomized Preference Trial

Do Clinical Trials of Treatment of Alcohol Dependence Adequately Enroll Participants With Co-Occurring Independent Mood and Anxiety Disorders? An Analysis of Data From the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC)

Trends in Office-Based Mental Health Care Provided by Psychiatrists and Primary Care Physicians

Article

A Prospective 4-Year Naturalistic Follow-Up of Treatment and Outcome of 300 Bipolar I and II Patients

Commentary

Schizophrenia: The Role of Dopamine and Glutamate

Clinical and Practical Psychopharmacology

Antidepressants and Testicular Cancer: Cause Versus Association

ASCP Corner

The Endocannabinoid System and Schizophrenia: Links to the Underlying Pathophysiology and to Novel Treatment Approaches

Letter to the Editor

High-Dose Cholinergic Therapy With Rivastigmine Patch Does Not Prolong QTc Time in Patients With Alzheimer's Disease

The Problem of Patient Heterogeneity and Lack of Proper Training in a Study of EEG Neurofeedback in Children

Dr van Dongen-Boomsma and Colleagues Reply

Correction: Continuation of Quetiapine Versus Switching to Placebo or Lithium for Maintenance Treatment of Bipolar I Disorder (Trial 144: A Randomized Controlled Study)

Educational Activity

Misdiagnosis of Bipolar Depression in Primary Care Practices

Common Comorbidities and Differential Diagnosis of Restless Legs Syndrome

Presentation and Treatment of Complicated Obsessive-Compulsive Disorder

Book Review

Cognitive-Behavior Therapy for Children and Adolescents

ELSEWHERE:

FOLLOW US:

Volume 75 • 2014 • 3

Review Article

Review of Maintenance Trials for Major Depressive Disorder: A 25-Year Perspective From the US Food and Drug Administration

Original Research

Completed and Attempted Suicides Among 18,154 Subjects With Schizophrenia Included in a Large Simple Trial

Violent and Serious Suicide Attempters: One Step Closer to Suicide?

Cost-Effectiveness of Prolonged Exposure Therapy Versus Pharmacotherapy and Treatment Choice in Posttraumatic Stress Disorder (the Optimizing PTSD Treatment Trial): A Doubly Randomized Preference Trial

Do Clinical Trials of Treatment of Alcohol Dependence Adequately Enroll Participants With Co-Occurring Independent Mood and Anxiety Disorders? An Analysis of Data From the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC)

Trends in Office-Based Mental Health Care Provided by Psychiatrists and Primary Care Physicians

Article

A Prospective 4-Year Naturalistic Follow-Up of Treatment and Outcome of 300 Bipolar I and II Patients

Commentary

Schizophrenia: The Role of Dopamine and Glutamate

Clinical and Practical Psychopharmacology

Antidepressants and Testicular Cancer: Cause Versus Association

ASCP Corner

The Endocannabinoid System and Schizophrenia: Links to the Underlying Pathophysiology and to Novel Treatment Approaches

Letter to the Editor

High-Dose Cholinergic Therapy With Rivastigmine Patch Does Not Prolong QTc Time in Patients With Alzheimer's Disease

The Problem of Patient Heterogeneity and Lack of Proper Training in a Study of EEG Neurofeedback in Children

Dr van Dongen-Boomsma and Colleagues Reply

Correction: Continuation of Quetiapine Versus Switching to Placebo or Lithium for Maintenance Treatment of Bipolar I Disorder (Trial 144: A Randomized Controlled Study)

Educational Activity

Misdiagnosis of Bipolar Depression in Primary Care Practices

Common Comorbidities and Differential Diagnosis of Restless Legs Syndrome

Presentation and Treatment of Complicated Obsessive-Compulsive Disorder

Book Review

Cognitive-Behavior Therapy for Children and Adolescents

Watch the New PsychCase360

Subscribe to readmore articles

Subscribe to read
more articles